The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

• Status: Completed
• Trial end date: 2020-06-20
• Target enrollment: 0
• Participant gender: All

Summary

72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jun Xiao
• Collaborator: Qingdao Fifth People's Hospital
• Treatments: Atropine

Criteria

Inclusion Criteria:

• Clinical diagnosis of hypertensive bradyarhhythmia

Exclusion Criteria:

• With other elementary diseases

• With pregnant

• With receiving other treatment within past half year from the beginning of trial.